'A Swiss pharmaceutical group has scrapped plans to conduct a major drug trial in the UK, damaging government efforts to showcase the country as an attractive destination for investment in life sciences after Brexit.'

https://www.ft.com/content/d7685eaa-5635-4e64-a390-b48908874bfe